Heart Risks After GLP-1 Hiatus; TED Drug Success; Top Diabetes Researcher Dies

(MedPage Today) -- A 6-month hiatus in GLP-1 drug use was linked with an increased risk of major adverse cardiovascular events in patients with type 2 diabetes compared with continued use, according to a target trial emulation. (BMJ Medicine)...
Source
MedPage Today
Opens original article in a new tab



